Table 2.
Kaplan–Meier estimates of retention on antiretroviral therapy, overall and for pregnant and non‐pregnant adults (percentage and 95% confidence interval)
| Entire cohort (n = 3170) | Advanced HIV disease (n = 1074) | |||
|---|---|---|---|---|
| Treat‐All (n = 1888) | SOC (n = 1282) | Treat‐All (n = 620) | SOC (n = 454) | |
| Retention, entire cohort | ||||
| 1 daya | 94 (93 to 95) | 97 (95 to 97) | 95 (93 to 96) | 95 (93 to 97) |
| 6 months | 84 (82 to 85) | 89 (87 to 90) | 81 (78 to 84) | 86 (82 to 89) |
| 12 months | 78 (76 to 80) | 83 (81 to 85) | 76 (73 to 80) | 81 (77 to 84) |
| 24 months | 72 (70 to 74) | 77 (75 to 79) | 70 (66 to 73) | 74 (70 to 78) |
| 36 months | 71 (69 to 73) | 75 (73 to 78) | 68 (64 to 71) | 72 (68 to 76) |
| Retention, non‐pregnant adults | ||||
| 1 daya | 95 (94 to 96) | 97 (96 to 98) | 96 (94 to 97) | 95 (92 to 97) |
| 6 months | 86 (84 to 88) | 90 (88 to 92) | 82 (78 to 85) | 86 (82 to 89) |
| 12 months | 81 (79 to 83) | 85 (83 to 87) | 76 (72 to 80) | 81 (77 to 84) |
| 24 months | 75 (73 to 77) | 79 (77 to 82) | 70 (66 to 74) | 75 (70 to 79) |
| 36 months | 74 (72 to 76) | 78 (75 to 80) | 68 (64 to 72) | 72 (67 to 76) |
| Retention, pregnant women | ||||
| 1 daya | 90 (87 to 93) | 94 (90 to 96) | 87 (77 to 93) | 97 (80 to 100) |
| 6 months | 77 (73 to 81) | 84 (79 to 88) | 79 (68 to 87) | 85 (67 to 93) |
| 12 months | 70 (65 to 74) | 77 (71 to 81) | 78 (67 to 86) | 75 (56 to 87) |
| 24 months | 62 (57 to 66) | 70 (64 to 75) | 69 (57 to 78) | 72 (53 to 84) |
| 36 months | 61 (56 to 65) | 67 (61 to 73) | 65 (53 to 75) | 72 (53 to 84) |
SOC, standard of care.
a
These patients never came back for a clinic visit after ART initiation.